Awards
2025 Public Service Award Winners
Recognizing the commitment and talent of all International Society for Stem Cell Research (ISSCR) volunteer leaders, the ISSCR Executive Committee is honoring members of committees, task forces, and working groups who dedicate tremendous talent and dedication to the ISSCR and its mission with the 2025 ISSCR Public Service Award. This is the first group award in the Society’s history and indicative of the ISSCR’s commitment to celebrate the excellence that fuels the tremendous accomplishments of the foremost global organization dedicated to stem cell science and regenerative medicine.
Learn more about the focus of ISSCR committees, task forces, and working groups that our recognized 211 volunteers contributed to over the last 12+ months.
2025 Annual Meeting Program Committee
The 2025 Annual Meeting Program Committee developed the scientific program for the ISSCR 2025 Annual Meeting in Hong Kong, 11-14 June 2025. It is a reflection of the stem cell research and regenerative medicine community at this moment in time, embracing the breadth of science in our community from stem cell biology through translation. Attendees will hear new and exciting voices in our field and a program of outstanding science and compelling conversation around policy, ethics, and regulatory topics.
2026 Annual Meeting Program Committee
ISSCR 2026 will be held in Montréal, Canada, 8-11 July 2026. Committee Co-chairs Fiona Doetsch and Nozomu Yachie, along with committee members, have developed the thematic tracks: Clinical Applications, Capturing Development, Disease Modeling, Engineering Biology, Global Stakeholder Initiatives, and Somatic Stem Cells. Speaker invitations are in process.
Early Career Advisory Committee
The committee hosted its first webinar on 11 March 2025, Communicating Science: Simplifying the Complex, which focused on science communication skills for early career scientists, from presenting your research at your poster session to exploring careers in communications. Planning is underway for another webinar later this year. The committee also organizes the annual Career Panel at the ISSCR Annual Meeting taking place on Friday, 13 June, Communicating, Connecting, and Leading through Your Science Degree, which will highlight the multifaceted opportunities available in stem cell science.
Education Committee
The ISSCR Education Committee’s current priority is the Clinician Education Initiative, which aims to establish the ISSCR as the primary educational resource for both stem cell scientists and medical professionals. It aims to foster collaboration between researchers and clinicians, empower the medical community, protect patients from unproven treatments, and accelerate the translation of stem cell research into clinical practice.
The committee has launched a new open-access, on-demand Continuing Education course, Stem Cell Medicine: From Scientific Research to Patient Care, jointly provided with and accredited by Harvard Medical School. Additional disease-specific courses on eye disorders, Parkinson’s disease, oncology, and diabetes are scheduled to release over the next year.
Ethics Committee
The Ethics Committee works to connect scientific advances in the stem cell field with implications for the public and society. Their passionate work is critical to properly guide science as well as for their capacity to consider what new ethical frameworks are necessary as research advances. Under the leadership of Erica Jonlin and Insoo Hyun, several committee members recently published a paper in Stem Cell Reports addressing what constitutes “adequate and appropriate scientific justification” for research involving human pluripotent stem cells, embryos, and related areas.
For ISSCR 2025, committee members organized the session, Emerging Ethical Issues with Neural Organoids, which explores emerging ethical issues in neural organoid research, including questions surrounding moral status, sourcing, and the use of in vitro and in vivo models.
The committee is also focused on enhancing ethics-related content across ISSCR websites. Going forward, the committee will address any gaps identified through its review of ethics-related content and consider developing new or supplemental materials as needed. Members often review and share feedback on ISSCR initiatives including the ISSCR Guidelines, Best Practices, and have contributed to the continuing education course developed by the Education Committee.
Finance Committee
Finance Committee members constantly monitor the financial health of the ISSCR – from cash flow to investments. This includes the ISSCR Annual Meeting and International Symposia hosted worldwide in Asia, Europe, and North and South America, along with a wide range of educational endeavors. Those priorities include public and regulatory policy initiatives that address the escalating, global concern of unproven stem cell clinics and ethics and standards for research and clinical trials using stem cells. Committee members also review the annual budget and tax audit and approve changes in spending priorities across all of the programs. One of the committee’s most important initiatives recently is lowering the cost of ISSCR membership and attendance at ISSCR meetings to foster a more diverse and inclusive global audience, while maintaining the Society’s firm financial position. There is a core focus on the need to ensure ISSCR has resources and operational staff to act on priorities identified by the membership and the Board of Directors.
Manufacturing, Clinical Translation, and Regulatory Committee (MCTR)
The mission of MCTR Committee is to facilitate translation of discovery research to clinical products. During the last 10 years, there has been great interest in creating stem cell therapies. One of the primary challenges for translation is navigating regulatory requirements. The committee is working to educate scientists about what regulators are looking for through meetings held with FDA, EMA, MHRA, and PMDA. Visit Regulatory Policy.
The committee is also assembling a global list of cell therapy manufacturers for use by ISSCR members working to develop cell therapies. A working group of committee members developed a detailed questionnaire for manufacturers to outline their capabilities and are creating a dedicated space on the ISSCR website for members to access this information. A supplemental document will also be created to support members in conducting risk assessments and due diligence when selecting a manufacturer.
Lastly, the committee is preparing to engage with a European regulatory agency through an Academic Briefing, continuing its commitment to dialogue and collaboration with regulators.
Membership and International Outreach Committee
The committee focuses on strategies to enhance members’ sense of community, awareness of member benefits, and to expanding membership and global engagement worldwide. With the go al of growing membership across the international community, the committee works with ISSCR staff to seek volunteers to translate ISSCR resources into various languages. Additionally, the committee works with ISSCR staff to ensure that the ISSCR Travel Awards that support attendance for students and post docs to attend the ISSCR Annual Meeting and reflect the scientific excellence, gender equity, and global diversity of the community.
Nominating and Awards Committees
The Nominations Committee is responsible for identifying, recruiting, and reviewing candidates for the Board of Directors and presenting a slate for annual elections. The ISSCR election for officers and directors is typically held each year in March and results announced in April.
The mission of the ISSCR Awards Program is to recognize, incentivize, and elevate work in the field of stem cell research and regenerative medicine. The Awards Committee oversees the process for the ISSCR portfolio of awards (Outstanding Young Investigator, Momentum, and Achievement).
Public Policy Committee
The ISSCR’s Public Policy Committee actively supports stem cell research and funding, advocates for scientific integrity and ethical research practices, works to prevent the premature marketing of unproven stem cell-based interventions, and facilitates scientifically informed regulatory decision-making. The committee monitors global issues and ensures the Society and its membership have a voice in policy decisions that impact the field. The Lawrence Goldstein Science Policy Fellowship Program contributes to the Public Policy Committee objectives by training the next generation of aspiring policy advocates to become leaders in the field. Visit Public Policy.
Scientific Programs Committee
The Scientific Programs Committee has been focused on restructuring and revising the composition of the Stem Cell Reports Editorial Board. Over the course of the past year, the committee selected the next cohort of Early Career Editorial Board (ECEB) members. First launched in 2022, the ECEB is an opportunity to mentor new group leaders in the review process and journal operations and contribute to journal activities. The committee has also established an Honorary Editorial Board for those who have served as advisors to the journal for 10 years or more.
The committee also considers subject matter for the symposia programming and seeks ways to drive synergies and opportunities between Stem Cell Reports and our meetings.
Strategic Oversight Committee
The Strategic Oversight Committee (SOC) oversees all committees in the Society. The span of topics that the ISSCR addresses is very broad: ethics, education, clinical translation, manufacturing and regulatory affairs, scientific programming, public policy, finances, membership and international outreach, early career members and more. The SOC’s role is to reflect on the remits and the composition of all committees and to ensure that they each have the representation and expertise needed to fulfill their strategic goals. Recently, the ISSCR restructured committees to ensure they were better aligned with the current strategic priorities and mission of the ISSCR, while ensuring internationality of membership. ISSCR also expanded the committees to include early career researchers and countries previously underrepresented so that the Society hears diverse perspectives and better captures the needs of the field.
Best Practices Task Force
Best Practices for the Development of Pluripotent Stem Cell-Derived Cellular Therapies is a comprehensive new resource designed to accelerate the translation of human pluripotent stem cell (PSC)-derived therapies into clinical trials and commercial use. Plans are to launch the open-access resource this summer.
Developed by leading international experts in cell therapy, this groundbreaking document outlines the key principles and decision points required to develop safe, effective, and regulatory- compliant PSC-derived products. Organized into seven sections, the guidance offers jurisdictionally neutral information on topics ranging from cell line selection and raw material use to regulatory considerations, preclinical studies, and clinical trials.
A webinar hosted in April, Best Practices for PSC-based Therapies is available on demand for ISSCR members.
Embryo Models Working Group
As research with stem cell-based embryo models advances rapidly, there is a growing need for updated guidance to accommodate scientific progress. To address this need, the ISSCR created the Embryo Models Working Group, tasking it with developing a white paper published in Stem Cell Reports that summarizes the state of the science, categorizes different types of embryo models, and proposes updates to the 2021 ISSCR Guidelines for Stem Cell Research and Clinical Translation. A webinar held in April, ISSCR Embryo Models Working Group Summary of Findings and Recommendations, shared group’s recommendations and how they will be incorporated into a forthcoming revision of the ISSCR Guidelines. The webinar is available on demand for ISSCR members.
2024 and 2025 International Symposia Organizing Committees
ISSCR International Symposia bring together specific scientific communities or disciplines (e.g., developmental biology, translational, tissue-specific research) to share their science, make connections, and exchange the ideas that drive the field forward.
In 2024 and 2025, ISSCR International Symposia programs include: Stem Cells in Human Development and Disease, Cincinnati, PSC-Derived Cell Therapies: Clinical Advances, NextGen Technologies, and the Path to Success, Copenhagen, Neural Stem Cells: Capturing Complexity and Plasticity from the Cell Organism, Athens, and AI and Digital Biology Symposium in Seattle, and Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind in Boston. Visit Upcoming Programs.
Congratulations to all of our committee, task force, and working groups on winning the 2025 Public Service Award!
Explore all the members below.
- 
      
        
          
        
      
      Chair - Kathryn SE Cheah, PhD 
 University of Hong Kong, ChinaChair - Eugenia Piddini, PhD, BSc, MSc 
 University of Bristol, UKAlessandro Aiuti, MD, PhD 
 San Raffaele Telethon Institute for Gene Therapy, ItalyVivian Gama, PhD 
 Vanderbilt University, USARichard J. Gilbertson, MD PhD 
 CRUK Cambridge Institute, UKLijian Hui, PhD 
 Shanghai Institute of Biochemistry and Cell Biology (SIBCB), ChinaTina Mukherjee, PhD 
 Institute for Stem Cell Science and Regenerative Medicine (inStem), IndiaLygia da Veiga Pereira, PhD 
 Universidade de São Paulo, BrazilKirsten Sadler Edepli, PhD 
 NYU Abu Dhabi, United Arab EmiratesTakanori Takebe, MD, PhD 
 Cincinnati Children's Hospital Medical Center, USA andOsaka University and Tokyo Medical and Dental University, JapanAngela R. Wu, PhD 
 Hong Kong University of Science and Technology, Hong KongJoseph C. Wu, MD PhD 
 Stanford University, USAEx Officio - Valentina Greco, PhD 
 Yale School of Medicine, Genetics Department & Yale Stem Cell Center, USA
- 
      
        
      
      Chair - Fiona Doetsch, PhD 
 Biozentrum, University of Basel, SwitzerlandChair – Nozomu Yachie, PhD 
 University of British Columbia, CanadaAllison Bardin, PhD 
 Institut Curie, FranceShuibing Chen, PhD 
 Weill Cornell Medical College, USAHongkui Deng, PhD 
 Peking University, ChinaStuart Forbes, PhD, FRCP 
 Institute for Stem Cell Research - University of Edinburgh, UKAnna-Katerina Hadjantonakis, PhD 
 Sloan-Kettering Institute for Cancer Research, USAMatthias P. Lutolf, PhD 
 École Polytechnique Fédérale de Lausanne (EPFL), SwitzerlandDasaradhi Palakodeti, PhD 
 Institute for Stem Cell Science and Regenerative Medicine, IndiaCatherine Priest, PhD 
 Neurona Therapeutics, USANika Shakiba, PhD 
 University of British Columbia, CanadaJian Shu, PhD 
 Harvard Medical School, USAShahragim Tajbakhsh, PhD 
 Institut Pasteur Stem Cells and Development, FranceEx Officio - Hideyuki Okano, MD, PhD 
 Keio University, Japan
- 
      
        
      
      Chair - Evan Graham, PhD 
 BioLamina Inc., USAVice Chair - Alessandro Bertero, PhD 
 Università di Torino, ItalyShuibing Chen, PhD 
 Weill Cornell Medicine, USANikolas Dresch Ferreira 
 University of São Paulo Medical School, BrazilElisa Giacomelli, PhD 
 Massachusetts General Hospital & Harvard Medical School, USAKelvin K. Hui 
 Center for iPS Cell Research and Application (CiRA), Kyoto University, JapanThomas Hutschalik 
 SCITARIS GmbH & Co. KG, GermanyRan Jing, PhD 
 Harvard Medical School & Boston Children's Hospital, USAOlivia Majhi 
 Banaras Hindu University, IndiaGraziano Martello, PhD 
 University of Padova, ItalyThulaj Meharwade 
 Stanford University, USAAnjie Ni 
 McGill University, CanadaAmelia Semenak 
 McGill University, CanadaHilary Toh 
 Duke-NUS Medical School, Singapore
- 
      
        
      
      Chair - Eugenia Piddini, PhD, BSc, MSc 
 University of Bristol, UKVice Chair – Jaime Imitola, MD, FAAN 
 UConn Health, USAMohamed Abou-el-Enein, MD, PhD, MSPH 
 Keck School of Medicine of USC, USAWilliam J. Anderson, PhD 
 Harvard Stem Cell and Regenerative Biology, USARoger Barker, MBBS, MRCP, PhD 
 University of Cambridge, UKKathryn S.E. Cheah, PhD 
 The University of Hong Kong, Hong KongAnna Couturier, PhD 
 EuroGCT, UKElisa Giacomelli, PhD 
 Massachusetts General Hospital, USAInsoo Hyun, PhD 
 Boston Museum of Science, USAKathryn S. Jones, PhD 
 University of Auckland, New ZealandSally Lowell, PhD 
 MRC Centre for Regenerative Medicine, University of Edinburgh, UKZubin Master, BSc, PhD 
 Wake Forest University School of Medicine, USAHideyuki Okano, MD, PhD 
 Keio University of School of Medicine, JapanGraziella Pellegrini, PhD 
 University of Modena and Reggio Emilia, Centre for Regenerative Medicine, ItalyCarolyn Sangokoya, MD, PhD 
 University of California, San Francisco (UCSF), USACecile Terrenoire, PhD 
 The New York Stem Cell Foundation, USA
- 
      
        
      
      Chair - Kazuto Kato, PhD 
 Osaka University Medical School, JapanVice Chair - Rosario Isasi, JD MPH 
 University of Miami, USANienke de Graeff, MA, MD, PhD 
 Leiden University Medical Center, NetherlandsMisao Fujita, MS, MPH, PhD 
 Center for iPS Cell Research and Application (CiRA), Kyoto University, JapanInsoo Hyun, PhD 
 Boston Museum of Science, USAErica C. Jonlin, PhD 
 University of Washington, USAMegan Munsie, PhD 
 Murdoch Children’s Research Institute & University of Melbourne , AustraliaKaori Muto, PhD 
 The Institute of Medical Science, The University of Tokyo, JapanKathy Niakan, PhD 
 University of Cambridge, UKKrishanu Saha, PhD 
 University of Wisconsin-Madison, USAJeremy Sugarman, MD, MPH, MA 
 Johns Hopkins University, USAZhaochen Wang, PhD 
 Peking Union Medical College, China
- 
      
        
      
      Provides oversight of ISSCR financial planning and activity to ensure future security of the Society, and within that, to fund responsibly activities and programs that ISSCR sees important to its mission, and to assess financial risk. Chair - Clive Svendsen, PhD 
 Cedars-Sinai Regenerative Medicine Institute, USAJennifer Brogdon, PhD 
 Novartis Institute for BioMedical Research, USAJane S. Lebkowski, PhD 
 Regenerative Patch Technologies, USALee Rubin, PhD 
 Harvard University Department of Stem Cell and Regenerative Biology, USAPaul J. Tesar, PhD 
 Case Western Reserve University, USAKenneth S. Zaret, PhD 
 University of Pennsylvania School of Medicine, USA
- 
      
        
      
      Chair - Melissa K. Carpenter, PhD 
 Carpenter Consulting Corporation, USAVice Chair - Tenneille E. Ludwig, PhD 
 WiCell, USARicardo Baptista, PhD 
 SmartCella, SwedenIvana Barbaric, DPhil 
 University of Sheffield, UKJacqueline Barry, PhD 
 Cell and Gene Therapy Catapult, UKAlessandro Bertero , PhD 
 Università di Torino, ItalyKapil Bharti, PhD 
 National Institutes of Health (NIH), USAAndrew Gaffney, PhD 
 STEMCELL Technologies Inc., CanadaDerek J. Hei, PhD 
 Kenai Therapeutics, USAZoe Hewitt, PhD 
 Regenerative Cell Therapy Consulting Limited, UKDeborah Hursh, PhD 
 Hursh Cell Therapy Consulting, LLC, USAUma Lakshmipathy, PhD 
 Thermo Fisher Scientific, USAJane S. Lebkowski, PhD 
 Regenerative Patch Technologies, USAMarinna Madrid, PhD 
 Cellino Biotech, USAJennifer Moody, PhD 
 Danaher Corporation, CanadaCharles Murry, MD, PhD 
 USC Stem Cell, USAYoji Sato, PhD 
 National Institute of Health Sciences, JapanJihwan Song, DPhil 
 CHA University, South KoreaYoshie Tsurumaki, Rph 
 Novartis, JapanDebra Webster, PhD 
 Aditum Bio, USA
- 
      
        
      
      Chair - Ole Pless, PhD, MSc 
 Fraunhofer ITMP, GermanyVice Chair - Athanasia D. Panopoulos, PhD 
 Cedars-Sinai Medical Center, USANissim Benvenisty, MD, PhD 
 Hebrew University, IsraelAndrea Ditadi, PhD 
 Ospedale San Raffaele, ItalyMubeen Goolam, PhD 
 University of Cape Town, South AfricaAkitsu Hotta, PhD 
 Kyoto University, JapanLijian Hui, PhD 
 Shanghai Institute of Biochemistry and Cell Biology (SIBCB), ChinaMadeline A. Lancaster, PhD 
 Medical Research Council (MRC), UKRebecca Matsas, PhD 
 Hellenic Pasteur Institute, GreeceSarah E. Millar, PhD 
 Icahn School of Medicine at Mount Sinai, USAVerónica Alejandra Palma, PhD 
 Universidad de Chile, ChileLygia da Veiga Pereira, PhD 
 University of São Paulo, BrazilEugenia Piddini, PhD, BSc, MSc 
 University of Bristol, UKNika Shakiba, PhD 
 University of British Columbia, CanadaJihwan Song, DPhil 
 CHA University, South KoreaShahragim Tajbakhsh, PhD 
 Institut Pasteur Stem Cells and Development, FranceSu-Yi Tsai, PhD 
 National Taiwan University, Taiwan
- 
      
        
          
        
      
      Chair - Amander T. Clark, PhD 
 University of California, Los Angeles (UCLA), USAMelissa K. Carpenter, PhD 
 Carpenter Consulting Corporation, USAValentina Greco, PhD 
 Yale School of Medicine, Genetics Department & Yale Stem Cell Center, USAArnold R. Kriegstein, MD, PhD 
 University of California, San Francisco, USAMelissa H. Little, AC, PhD Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Denmark & Murdoch Children's Research Institute, Australia 
 Christine L. Mummery, PhD
 Leiden University Medical Center, NetherlandsKathy Niakan, PhD 
 University of Cambridge, UKHideyuki Okano, MD, PhD 
 Keio University of School of Medicine, JapanLorenz Studer, MD 
 Sloan-Kettering Institute for Cancer Research, USA
- 
      
        
      
      Allison Bardin, PhD 
 Institut Curie, FranceHongkui Deng, PhD 
 Peking University, ChinaAndrea Ditadi, PhD 
 San Raffaele Telethon Institute for Gene Therapy, ItalyFiona Doetsch, PhD 
 University of Basel, SwitzerlandStuart Forbes, PhD, FRCP 
 Institute for Stem Cell Research - University of Edinburgh, United KingdomValentina Fossati 
 New York Stem Cell Foundation, USAManeesha Inamdar, PhD 
 Jawaharlal Nehru Centre for Advanced Scientific Research, IndiaKai Kretzschmar, PhD 
 University Hospital Würzburg, GermanyArnold R. Kriegstein, MD, PhD 
 University of California, San Francisco (UCSF), USARavi Majeti, MD, PhD 
 Stanford University, United StatesRebecca Matsas, PhD 
 Hellenic Pasteur Institute, GreeceSarah E. Millar, PhDt 
 Icahn School of Medicine at Mount Sinai, USATina Mukherjee, PhD 
 Institute for Stem Cell Science and Regenerative Medicine, IndiaKathy Niakan, PhD 
 University of Cambridge, UKNathan Palpant, PhD 
 The University of Queensland, AustraliaOle Pless, PhD, MSc 
 Fraunhofer ITMP, GermanyLygia da Veiga Pereira, PhD 
 University of São Paulo, BrazilMarimelia Porcionatto, PhD 
 Federal University of São Paulo, BrazilOwen Rackham, PhD, MSc 
 University of Southampton, UKThomas A. Rando, MD, PhD 
 University of California, Los Angeles (UCLA), USAJanet Rossant, PhD, FRS 
 The Hospital for Sick Children, CanadaNika Shakiba, PhD 
 University of British Columbia, CanadaYue Shao 
 Tsinghua University, ChinaViviane Tabar, MD, FAANS 
 Sloan-Kettering Institute for Cancer Research, USAYun Xia, PhD 
 Nanyang Technological University, SingaporeWei Xie, PhD 
 Tsinghua University, China
- 
      
        
      
      Chair - Sean J. Morrison, PhD 
 Children's Medical Research Institute at UT Southwestern, USAEric Anthony 
 University of California, San Francisco (UCSF), USAR. Alta Charo, JD 
 University of Wisconsin, USAGeorge Q. Daley, MD, PhD 
 Harvard Medical School, USALawrence S.B. Goldstein, PhD 
 University of California San Diego, USAKazuto Kato, PhD 
 Osaka University Medical School, JapanRobin Lovell-Badge, PhD, FRS 
 The Francis Crick Institute, UKZubin Master, BSc, PhD 
 Wake Forest University School of Medicine, USASarah E. Millar, PhD 
 Icahn School of Medicine at Mount Sinai, USAMegan Munsie, PhD 
 Murdoch Children’s Research Institute & University of Melbourne , AustraliaMalin Parmar, PhD 
 Lund University, SwedenYaojin Peng, PhD 
 Chinese Academy of Sciences, ChinaDouglas Sipp 
 RIKEN Center for Biosystems Dynamics, JapanJeremy Sugarman, MD, MPH, MA 
 Johns Hopkins University, USAGiuseppe Testa, MD PhD MA 
 Foundation Human Technopole, ItalyAlan O. Trounson, MSc PhD 
 Monash University, AustraliaFiona Watt, PhD 
 King's College London, UKMagdalena Zernicka-Goetz, PhD 
 California Institute of Technology, USAEx Officio - Mubeen Goolam, PhD 
 University of Cape Town, South AfricaEx Officio - Lizhong Liu, PhD 
 Westlake University, ChinaEx Officio - Kate MacDuffie, MA., PhD 
 Seattle Children’s Research Institute, USAPrevious Goldstein Fellows who served through 2024: Brian Aguado, PhD 
 University of California San Diego, USAJustin Brumbaugh, PhD 
 University of Colorado, USATamra Lysaght, PhD 
 University of Sydney, Australia
- 
      
        
      
      Provides oversight of the Society’s scientific publishing activities, including the society journal, Stem Cell Reports, and advises on the editorial calendar of meetings outside the Annual Meeting. This includes concepts for webinar and symposia programming, and review of grassroots proposals. The committee ensures content and programs are complementary, aligned with Society strategic priorities, and in keeping with ISSCR’s standards for excellence and rigor. Chair - Eran Meshorer, PhD 
 The Hebrew University of Jerusalem Institute of Life Sciences, IsraelVice Chair - Wei Xie, PhD 
 Tsinghua University, ChinaAllison Bardin, PhD 
 Institut Curie, FranceGray Camp, PhD 
 Roche Institute for Translational Bioengineering, SwitzerlandMaria Pia Cosma, PhD 
 Centre for Genomic Regulation, SpainFiona Doetsch, PhD 
 Biozentrum, University of Basel, SwitzerlandJianping Fu, PhD 
 University of Michigan, USARuwanthi Gunawardane, PhD 
 Allen Institute, USAKarl R. Koehler, PhD 
 Boston Children's Hospital and Harvard Medical School, USAHanna Mikkola, MD, PhD 
 University of California, Los Angeles, USAJing Qu, PhD 
 Institute of Zoology, Chinese Academy of Sciences (CAS), ChinaKaelyn Sumigray, PhD 
 Yale School of Medicine, USASara Wickström, MD, PhD 
 Max Planck Institute for Molecular Biomedicine, GermanyEx Officio - Janet Rossant, CC, PhD, Stem Cell Reports Editor-in-Chief and The Gairdner Foundation, Toronto, ON, Canada 
- 
      
        
      
      Chair - Fiona Doetsch, PhD 
 Biozentrum, University of Basel, SwitzerlandAmander T. Clark, PhD 
 University of California, Los Angeles, USAHongkui Deng, PhD 
 Peking University, ChinaArnold R. Kriegstein, MD, PhD 
 University of California, San Francisco (UCSF), USAJane S. Lebkowski, PhD 
 Regenerative Patch Technologies, USAChristine L. Mummery, PhD 
 Leiden University Medical Center, NetherlandsKathy Niakan, PhD 
 University of Cambridge, UKTakanori Takebe, MD, PhD 
 Cincinnati Children's Hospital Medical Center, USA & Osaka University and Institute of Science Tokyo, JapanSally Temple, PhD 
 Neural Stem Cell Institute, USAJoanna Wysocka, PhD 
 Stanford University, USAEx Officio - Hideyuki Okano, PhD 
 Keio University of School of Medicine, Japan
- 
      
        
      
      Co-Chair - Amander T. Clark, PhD 
 UCLA, USACo-Chair - Janet Rossant, PhD, FRS 
 The Hospital for Sick Children, CanadaHeidi Cook-Andersen 
 UCSD, USASarah Franklin 
 University of Cambridge, UKRosario Isasi, JD MPH 
 University of Miami, USADebra JH Mathews, PhD, MA 
 Johns Hopkins University, USAVincent Pasque, PhD 
 Katholieke Universiteit Leuven, BelgiumPeter Rugg-Gunn 
 Babraham Institute, UKPatrick P.L. Tam, PhD 
 Children’s Medical Research Institute, AustraliaHongmei Wang, PhD 
 Institute of Zoology, Chinese Academy of Sciences (CAS), ChinaXiaomei Zhai, PhD 
 Chinese Academy of Medical Sciences, ChinaJan Jakub Zylicz, PhD 
 University of Copenhagen, Denmark
- 
      
        
      
      Steering Committee Co-Chair - Kapil Bharti, PhD 
 National Institutes of Health (NIH), United StatesCo-Chair - Jacqueline Barry, PhD 
 Cell and Gene Therapy Catapult, United KingdomRicardo Baptista, PhD 
 SmartCella, SwedenMelissa K. Carpenter, PhD 
 Carpenter Consulting Corp, United StatesDerek J. Hei, PhD 
 Kenai Therapeutics, United StatesAna Hidalgo Simon, MD, PhD 
 Leiden University Medical Centre, NetherlandsDeborah Hursh, PhD 
 Hursh Cell Therapy Consulting, LLC, United StatesJung-Hyun Kim, PhD 
 AJOU UNIVERSITY SCHOOL OF PHARMACY, South KoreaTenneille E. Ludwig, PhD 
 WiCell, United StatesHideyuki Okano, MD, PhD 
 Keio University, JapanJohn EJ Rasko 
 Royal Prince Alfred Hospital, SLHD, AustraliaYoji Sato, PhD 
 National Institute of Health Sciences, JapanGlyn Stacey, PhD, MPhil 
 International Stem Cell Banking Initiative, United KingdomClive Svendsen, PhD 
 Cedars-Sinai Board of Governors Regenerative Medicine Institute, United StatesAncillary Raw Materials & Devices Working Group Elsa Abranches, PhD 
 ViSync Technologies, PortugalKevin Bruce 
 Roslin Cell Therapies, United KingdomTamar Harel Adar 
 Matricelf, IsraelUma Lakshmipathy, PhD 
 Thermo Fisher Scientific, United StatesAnnelie Persson 
 Astra Zeneca, SwedenAnat Shnaiderman 
 MatriCelf, IsraelShuyan Wang 
 Zephyrm, ChinaClaudia Zylberberg, PhD 
 Akron Biotech, United StatesBanking Working Group Elsa Abranches, PhD 
 ViSync Technologies, PortugalJie Hao 
 National Stem Cell Resource Center, ChinaHyunyoung Kim 
 KNIH, South KoreaJoanne Mountford 
 Scottish National Blood Transfusion Service, United KingdomClinical Trials Working Group Claire Henchcliffe, DPhil, MD 
 University of California, Irvine, United StatesStanley Lazic, MPhil 
 Prioris.ai IncGraziella Pellegrini, PhD 
 University of Modena and Reggio Emilia, ItalyAlan O. Trounson, MSc PhD 
 Monash University, AustraliaSowmya Viswanathan, PhD 
 University Health Network, Princess Margaret Hospital, CanadaKirsty Wydenbach 
 MHRAConsultantDrug Substance/Product Working Group Jennifer Dashnau 
 Century Therapeutics, United StatesKate Fynes 
 EXmoor Pharma, United KingdomJennifer Hollands, PhD 
 Cell Therapies Pty Ltd, AustraliaMasahiro Kino-oka, PhD 
 Osaka University, JapanDhruv Sareern 
 CS Biomanufacturing Center, United StatesPre-Clinical Trials Working Group Joy Cavagnaro 
 Access Bio, United StatesLila Collins, PhD 
 CIRM, United StatesShawna M. Jackman 
 Charles River Laboratories, United StatesJeanne F. Loring, PhD 
 Scripps Research Institute (The), United StatesChristelle Monville, PhD 
 Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, FranceRegulatory Working Group Michela Gabaldo 
 Evotec SE, ItalyKilian Kelly, PhD, MPharm 
 Cynata Therapeutics, AustraliaSowmya Viswanathan, PhD 
 University Health Network, Princess Margaret Hospital, CanadaStarting Materials Working Group Catharina Brandsten, PhD, DDS 
 Takara Bio Europe, SwedenElizabeth Csaszar, PhD 
 Notch Therapeutics, CanadaIndumathi Mariappan, PhD 
 L V Prasad Eye Institute, Hyderabad, India, IndiaMark Tomishima, Ph.D. 
 BlueRock Therapeutics, United StatesAlex Zhang 
 Zephyrm Biotechnologies, China
- 
      
        
      
      2024 Copenhagen International Symposium Organizing Committee Co-Chair - Melissa K. Carpenter, PhD 
 Carpenter Consulting Corp, United StatesCo-Chair - Kapil Bharti, PhD 
 National Institutes of Health (NIH), United StatesBrendan Christopher Jones, MBBS PhD 
 Novo Nordisk A/S, DenmarkCharis Segeritz-Walko, PhD 
 Novo Nordisk A/S, DenmarkLorenz Studer, MD 
 Memorial Sloan Kettering Cancer Center, United StatesMasayo Takahashi, MD, PhD 
 Vision Care, Inc., Japan2024 Singapore International Symposium Organizing Committee Co-Chair - Kim B. Jensen, PhD 
 University of Copenhagen, DenmarkCo-Chair - Jonathan Yuin-Han Loh, PhD 
 Agency for Science, Technology and Research (A*Star), SingaporeRay Dunn, PhD 
 Vertex Pharmaceuticals, United StatesAnna-Katerina Hadjantonakis, PhD 
 Sloan-Kettering Institute for Cancer Research, United StatesBon-Kyoung Koo 
 Institute for Basic Science, South KoreaHideyuki Okano, MD, PhD 
 Keio University, JapanYun Xia, PhD 
 Nanyang Technological University, Singapore2025 Athens International Symposium Organizing Committee Co-Chair - Rebecca Matsas, PhD 
 Hellenic Pasteur Institute, GreeceCo-Chair - Fiona Doetsch, PhD 
 University of Basel, SwitzerlandMarie Engelene J. Obien 
 MaxWell Biosystems AG, SwitzerlandFlorentia Papastefanaki 
 Hellenic Pasteur Institute, GreeceEra Taoufik, PhD 
 Hellenic Pasteur Institute, GreeceHynek Wichterle, PhD 
 Columbia University, United States2025 Seattle International Symposium Organizing Committee Co-Chair - Ajamete Kaykas, PhD 
 Insitro, United StatesCo-Chair - Cole Trapnell, PhD 
 University of Washington, United StatesRafael Edgardo Carazo Salas, PhD 
 CellVoyant, United KingdomTheofanis Karaletsos, PhD 
 Chan Zuckerberg Initiative, United StatesBar Makovoz, PhD 
 Cellino Biotech, United StatesJian Shu, PhD 
 Harvard University, United StatesChristina Theodoris, MD, PhD 
 Gladstone Institutes, United States2025 Boston International Symposium Organizing Committee Co-Chair - Claire Henchcliffe, DPhil MD 
 University of California, Irvine, United StatesCo-Chair - Erin A. Kimbrel, PhD 
 Astellas Institute for Regenerative Medicine, United StatesThomas H.R. Carlsen, PhD 
 Novo Nordisk Foundation Cellerator, DenmarkAna Hidalgo Simon, MD, PhD 
 Leiden University Medical Centre, Netherlands
 Stefan Irion, MD
 BlueRock Therapeutics, United StatesFelicia Pagliuca, PhD 
 Vertex Pharmaceuticals, United States
 
                         
            
              
            
            
          
             
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
             
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
              